UNSPSC 51102906: Artenimol/piperaquine

Definition: This classification is for a combination antimalarial drug. The first component, ARTENIMOL, has a US FDA Unique Ingredient Identifier of 6A9O50735X. The second component, PIPERAQUINE, has a US FDA Unique Ingredient Identifier of A0HV2Q956Y.

UNSPSC 51102906 Artenimol/piperaquine is a Commodity code that names a single antimalarial pharmaceutical product. State and local procurement activity under this code shows little relevant recent solicitation. Of the recent opportunities tagged with this code, none involve artenimol/piperaquine or other prescription antimalarial drugs. The tagged records include a county purchasing department relocation notice, a Florida county's procurement of naloxone and drug deactivation systems for community health, a city fire department's solicitation for emergency medical services pharmaceuticals and supplies, and a multistate cooperative's RFP for generic pharmaceuticals and OTC products distributed through authorized wholesalers. None of these solicitations align with artenimol/piperaquine acquisition or use, suggesting a coding mismatch in the state and local procurement database rather than genuine demand signals under this Commodity code.

The code appears dormant for practical business development purposes at the state and local level. If artenimol/piperaquine sourcing were underway, it would likely surface within broader tropical medicine or public health agency procurement streams, possibly at state health departments supporting malaria treatment protocols or through international health initiatives. Present activity under this code does not support pursuit as a near-term opportunity without evidence of actual artenimol/piperaquine demand from state health authorities, counties, or regional health systems.